Compare MEDP & TKO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MEDP | TKO |
|---|---|---|
| Founded | 1992 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.4B | 14.5B |
| IPO Year | 2016 | N/A |
| Metric | MEDP | TKO |
|---|---|---|
| Price | $557.87 | $207.50 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 12 | 17 |
| Target Price | ★ $465.18 | $222.31 |
| AVG Volume (30 Days) | 265.4K | ★ 1.2M |
| Earning Date | 10-22-2025 | 11-05-2025 |
| Dividend Yield | N/A | ★ 1.50% |
| EPS Growth | ★ 25.36 | N/A |
| EPS | ★ 14.32 | 1.85 |
| Revenue | $2,358,373,000.00 | ★ $2,545,175,000.00 |
| Revenue This Year | $21.48 | $69.99 |
| Revenue Next Year | $11.90 | $29.75 |
| P/E Ratio | ★ $38.96 | $112.36 |
| Revenue Growth | ★ 13.88 | N/A |
| 52 Week Low | $250.05 | $133.07 |
| 52 Week High | $626.26 | $212.49 |
| Indicator | MEDP | TKO |
|---|---|---|
| Relative Strength Index (RSI) | 43.68 | 68.55 |
| Support Level | $530.96 | $190.21 |
| Resistance Level | $569.00 | $206.70 |
| Average True Range (ATR) | 16.60 | 5.81 |
| MACD | -4.63 | 1.57 |
| Stochastic Oscillator | 28.24 | 93.09 |
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
TKO Group Holdings Inc is a sports and sports entertainment company that operates combat sports and sports entertainment companies. It owns and manages valuable sports and entertainment intellectual property. The company distributes content and monetizes its intellectual property through four principal activities: Media Rights and Content, Live Events, Sponsorship, and Consumer Products Licensing. The company has two reportable segments, UFC and WWE. The company generates majority of revenue from the UFC segment. The UFC segment revenue consists of media rights fees associated with the distribution of its programming content, ticket sales, and site fees associated with the business's international live events, sponsorship, and consumer products licensing agreements of UFC-branded products.